School Of Medicine
-
Dr. Levi Watkins, Jr. Lecture: ‘A Conversation on Race, Training and Care at Vanderbilt’ Oct. 24
The 22nd annual Levi Watkins, Jr. M.D. Lecture will be delivered by Dr. John Sergent, Vice Chair Emeritus for Education, professor of medicine and associate director of the Internal Medicine Residency Program. Read MoreOct 4, 2023
-
Two Vanderbilt School of Medicine Ph.D. students, their faculty advisers selected for HHMI Gilliam Fellows Program
Four Vanderbilt graduate students, faculty advisers named to Howard Hughes Medical Institute Gilliam Fellows Program for their leadership in science and commitment to advancing equity and inclusion in science. Read MoreAug 4, 2023
-
MIDP students drive empathetic medical innovation
A clinical patient encounter led two Medical Innovators Development Program students to develop a potentially life-saving technology through an industry immersion experience with GE HealthCare. Read MoreFeb 27, 2023
-
UPDATED: School of Medicine invests in future of health care with Dean’s Scholarship Challenge
At the beginning of 2022, the School of Medicine launched a $5 million Dean’s Scholarship Challenge to help ensure that tomorrow’s leaders in medicine are educated at Vanderbilt. The success of the early months of the effort has prompted the university to boost the available matching funds by $5 million. Read MoreAug 2, 2022
-
Research Snapshot: Vanderbilt researchers discover new spontaneous signaling pathway in the brain
Ege Kavalali and Heidi Hamm collaborated to discover a signaling pathway for how spontaneous release of neurotransmitters can be selectively regulated without disrupting evoked action potentials. Read MoreFeb 14, 2022
-
Science and Strategy: Dr. Alex Jahangir draws on lessons from trauma surgery and management classes to lead Nashville’s response to COVID-19
As head of the Metro Nashville Coronavirus Task Force, Jahangir has helped coordinate local health systems and community groups, addressed the city at daily media briefings, set up COVID test sites and advised policymakers on combatting the virus, all while maintaining his normal duties at Vanderbilt. Read MoreOct 25, 2021
-
Patricia Frist, BA’61, Philanthropist and Community Leader
Patricia Gail “Trish” Champion Frist, BA’61, of Nashville, who had a great impact as a philanthropist and business advocate, died Jan. 5. Read MoreApr 22, 2021
-
Genetic differences in Wilms tumor
Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer. Read MoreApr 6, 2021
-
Shot in the Arm: Groundbreaking COVID-19 vaccine research by alumnus Dr. Barney Graham began at Vanderbilt decades ago
The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read MoreMar 17, 2021
-
Ask an Expert: Why is it still vital to follow COVID-19 safety protocols upon receiving the vaccine?
Vanderbilt University Senior Associate Dean for Health Sciences Education and Professor of Medicine Donald W. Brady discusses the importance of continuing to follow COVID-19 health and safety protocols even after receiving the vaccine during the Spring Return to Campus Town Hall on Jan. 13, 2021. Read MoreFeb 1, 2021
-
Alumni and faculty among Nashville Business Journal ’40 under 40′ honorees
(Anne Rayner/Vanderbilt) Nashville Business Journal recently released its 2021 “40 under 40” list of honorees, featuring six Vanderbilt alumni and two faculty members: Maya Bugg, EdD’18, president and CEO, Tennessee Charter School Center Christiane Buggs, MEd’14, board chair, The Metropolitan Nashville Board of Public Education and founding board member… Read MoreJan 12, 2021
-
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read MoreNov 18, 2020
-
Statins to be studied for prevention of dementia, disability and heart disease
Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. Read MoreNov 17, 2020
-
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read MoreNov 16, 2020
-
Consuelo Wilkins’ transformative public health engagement methods recognized with National Academy of Medicine election
Consuelo Hopkins Wilkins, professor of medicine in the School of Medicine and vice president for health equity at Vanderbilt University Medical Center, has received one of the highest honors in health and medicine. Read MoreNov 13, 2020
-
Breast cancer treatment in older women
A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read MoreNov 12, 2020
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNov 10, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNov 9, 2020
-
Former Vanderbilt Prize winner Amon mourned
Angelika Amon, PhD, a pioneering cell and molecular biologist and winner of the 2018 Vanderbilt Prize in Biomedical Science, died Oct. 29 from cancer. She was 53. Read MoreOct 30, 2020
-
Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth
Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read MoreOct 15, 2020